Holen Sie sich die Stockscreener-App
2.22
6.33%
-0.15
Schlusskurs vom Vortag:
$2.37
Offen:
$2.38
24-Stunden-Volumen:
366.88K
Relative Volume:
0.44
Marktkapitalisierung:
$200.39M
Einnahmen:
$70.14M
Nettoeinkommen (Verlust:
$-76.24M
KGV:
-2.00
EPS:
-1.11
Netto-Cashflow:
$-57.06M
1W Leistung:
-14.62%
1M Leistung:
-12.60%
6M Leistung:
-11.90%
1J Leistung:
-36.57%
1-Tages-Spanne:
$2.22
$2.38
1-Wochen-Bereich:
$2.22
$2.73
52-Wochen-Spanne:
$1.90
$6.08
Codexis Inc Stock (CDXS) Company Profile
Firmenname
Codexis Inc
Sektor
Branche
Telefon
650-421-8100
Adresse
200 PENOBSCOT DRIVE, REDWOOD CITY, CA
Vergleichen Sie CDXS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CDXS
Codexis Inc
|
2.22 | 213.93M | 70.14M | -76.24M | -57.06M | -1.11 |
|
VRTX
Vertex Pharmaceuticals Inc
|
424.22 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
639.64 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
429.68 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
824.41 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.59 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Codexis Inc Stock (CDXS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-08-19 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2024-06-03 | Fortgesetzt | Jefferies | Buy |
| 2024-05-30 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-02-29 | Hochstufung | The Benchmark Company | Hold → Buy |
| 2023-11-07 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2023-08-07 | Herabstufung | TD Cowen | Outperform → Market Perform |
| 2023-05-09 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2022-03-31 | Fortgesetzt | Piper Sandler | Overweight |
| 2022-03-02 | Fortgesetzt | Cowen | Outperform |
| 2021-04-12 | Eingeleitet | Piper Sandler | Overweight |
| 2021-03-01 | Eingeleitet | Stifel | Buy |
| 2021-02-26 | Bestätigt | H.C. Wainwright | Buy |
| 2020-03-10 | Eingeleitet | The Benchmark Company | Buy |
| 2019-01-17 | Hochstufung | First Analysis Sec | Neutral → Outperform |
| 2018-05-16 | Eingeleitet | Stephens | Overweight |
| 2017-10-13 | Bestätigt | H.C. Wainwright | Buy |
| 2017-05-31 | Eingeleitet | Jefferies | Buy |
| 2017-01-26 | Herabstufung | First Analysis Sec | Overweight → Equal-Weight |
| 2017-01-04 | Hochstufung | Ladenburg Thalmann | Neutral → Buy |
| 2016-01-06 | Eingeleitet | H.C. Wainwright | Buy |
Alle ansehen
Codexis Inc Aktie (CDXS) Neueste Nachrichten
Can volume confirm reversal in Codexis Inc.Market Performance Summary & Weekly High Potential Alerts - newser.com
Will Codexis Inc. stock outperform tech sector in 2025Market Growth Report & Reliable Price Action Trade Plans - newser.com
How to escape a deep drawdown in Codexis Inc.IPO Watch & Technical Entry and Exit Tips - newser.com
What MACD signals say about Codexis Inc.2025 Institutional Moves & Accurate Trade Setup Notifications - newser.com
Is Codexis Inc. stock dividend yield sustainable2025 Short Interest & Target Return Focused Stock Picks - newser.com
Is Codexis Inc. meeting your algorithmic filter criteriaEntry Point & Safe Capital Investment Plans - newser.com
Why Codexis Inc. stock is considered a top pickJuly 2025 Opening Moves & Reliable Price Action Trade Plans - newser.com
How Codexis Inc. stock trades before earningsJuly 2025 Analyst Calls & AI Enhanced Trading Signals - newser.com
Is Codexis Inc. stock a safe investment in uncertain markets2025 Historical Comparison & Advanced Swing Trade Entry Plans - newser.com
What risks investors should watch in Codexis Inc. stockJuly 2025 PostEarnings & Step-by-Step Swing Trade Plans - newser.com
Is Codexis Inc. forming a reversal patternRecession Risk & AI Forecast Swing Trade Picks - newser.com
How Codexis Inc. stock benefits from strong dollarJuly 2025 Update & AI Forecasted Entry/Exit Points - newser.com
How hedge fund analytics apply to Codexis Inc. stockPortfolio Performance Summary & High Accuracy Buy Signal Tips - newser.com
How to use Fibonacci retracement on Codexis Inc.Quarterly Performance Summary & Low Risk High Win Rate Picks - newser.com
Detecting price anomalies in Codexis Inc. with AIEarnings Trend Report & Long Hold Capital Preservation Plans - newser.com
Strategies to average down on Codexis Inc.Analyst Upgrade & Verified Swing Trading Watchlists - newser.com
Codexis, Inc. $CDXS Position Boosted by Pier Capital LLC - MarketBeat
Will Codexis Inc. stock outperform Dow Jones index2025 AllTime Highs & Accurate Entry/Exit Alerts - newser.com
How to build a dashboard for Codexis Inc. stockNew Guidance & Smart Money Movement Alerts - newser.com
Codexis (NASDAQ:CDXS investor five-year losses grow to 84% as the stock sheds US$29m this past week - simplywall.st
Will Codexis Inc. price bounce be sustainableJuly 2025 Review & Technical Pattern Recognition Alerts - newser.com
How Codexis Inc. stock reacts to oil pricesQuarterly Profit Report & Risk Managed Investment Strategies - newser.com
Can swing trading help recover from Codexis Inc. losses2025 Trading Recap & Real-Time Chart Pattern Alerts - newser.com
Codexis and Nitto Denko Avecia Enter Evaluation Agreement to Explore Codexis's Eco Synthesis®? Manufacturing Platform for Therapeutic siRNA Manufacturing - MarketScreener
Codexis (CDXS) Enters Evaluation Partnership with Nitto Denko Av - GuruFocus
Codexis and Nitto Denko Avecia Enter Evaluation Agreement to Explore Codexis's ECO Synthesis® Manufacturing Platform for Therapeutic siRNA Manufacturing - Yahoo Finance
Finanzdaten der Codexis Inc-Aktie (CDXS)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.27%
0.05%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):